Delivery Order SPE2D021D0004-SPE2D026F0120
Award Date 3/19/26
Potential Completion Date 4/26/27
Potential Value $248K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division issued a $1,997.50 delivery order to DMS Pharmaceutical Group Inc. on March 19, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. Place of performance is Park Ridge, IL. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is firm fixed price with an ultimate completion date of March 19, 2026. The parent PPV-G GEN V contract,...
- The Defense Logistics Agency issued a $138,412.45 delivery order to DMS Pharmaceutical Group Inc. on March 13, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical and medical consumables supply. DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract, PPV-G GEN V, is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency issued a $4,966.25 delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract, PPV-G GEN V, is a Defense Logistics Agency Indefinite Delivery Contract with a ceiling value of $499,999,999 and an ultimate completion date of December 31, 2036, supporting recurring...
- The Defense Logistics Agency issued a $65,066.40 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense medical facilities worldwide; DMS Pharmaceutical Group's...
- The Defense Logistics Agency Medical Supply Chain issued a $11,280 delivery order to DMS Pharmaceutical Group Inc. on December 19, 2025, for pharmaceutical supply. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), with a ceiling value of $4,361.95. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is placed against the company's single-award Indefinite Delivery Contract under the Defense Logistics Agency's PPV-G GEN V initiative, a $499.999 billion...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, with a ceiling value of $2,620.44 for pharmaceutical products. This order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's single-award indefinite delivery contract that authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a $1,294.01 delivery order to DMS Pharmaceutical Group Inc. on March 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical distribution to Department of Defense healthcare facilities worldwide; DMS Pharmaceutical Group holds a...
- The Defense Logistics Agency issued a $1,186.64 delivery order to DMS Pharmaceutical Group Inc. on March 7, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide, with a $499.9...
- The Defense Logistics Agency issued a $165,371.96 delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. DMS Pharmaceutical Group is a woman-owned small business. The parent IDC, awarded November 13, 2025, carries a $499,999,999 ceiling and an ultimate completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. PPV-G GEN V...